122 related articles for article (PubMed ID: 18304729)
1. Effects of adjuvant chemotherapy on bone marrow mesenchymal stem cells of colorectal cancer patients.
Cao J; Tan MH; Yang P; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ
Cancer Lett; 2008 May; 263(2):197-203. PubMed ID: 18304729
[TBL] [Abstract][Full Text] [Related]
2. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions.
Seebach C; Henrich D; Tewksbury R; Wilhelm K; Marzi I
Calcif Tissue Int; 2007 Apr; 80(4):294-300. PubMed ID: 17431529
[TBL] [Abstract][Full Text] [Related]
3. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
4. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction.
Mueller LP; Luetzkendorf J; Mueller T; Reichelt K; Simon H; Schmoll HJ
Stem Cells; 2006 Dec; 24(12):2753-65. PubMed ID: 16931776
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients.
Prata Kde L; Orellana MD; De Santis GC; Kashima S; Fontes AM; Carrara Rde C; Palma PV; Neder L; Covas DT
Exp Hematol; 2010 Apr; 38(4):292-300.e4. PubMed ID: 20138957
[TBL] [Abstract][Full Text] [Related]
8. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
[TBL] [Abstract][Full Text] [Related]
9. Substance P stimulates the recovery of bone marrow after the irradiation.
An YS; Lee E; Kang MH; Hong HS; Kim MR; Jang WS; Son Y; Yi JY
J Cell Physiol; 2011 May; 226(5):1204-13. PubMed ID: 20945355
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.
Kemp K; Morse R; Wexler S; Cox C; Mallam E; Hows J; Donaldson C
Ann Hematol; 2010 Jul; 89(7):701-13. PubMed ID: 20119670
[TBL] [Abstract][Full Text] [Related]
12. Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.
Coipeau P; Rosset P; Langonne A; Gaillard J; Delorme B; Rico A; Domenech J; Charbord P; Sensebe L
Cytotherapy; 2009; 11(5):584-94. PubMed ID: 19626496
[TBL] [Abstract][Full Text] [Related]
13. Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells.
Kemp K; Morse R; Sanders K; Hows J; Donaldson C
Ann Hematol; 2011 Jul; 90(7):777-89. PubMed ID: 21234567
[TBL] [Abstract][Full Text] [Related]
14. IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy.
Hernando Insúa A; Montaner AD; Rodriguez JM; Elías F; Fló J; López RA; Zorzopulos J; Hofer EL; Chasseing NA
Stem Cells; 2007 Apr; 25(4):1047-54. PubMed ID: 17420228
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage.
Fu X; He Y; Xie C; Liu W
Cytotherapy; 2008; 10(4):353-63. PubMed ID: 18574768
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
17. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine.
Antonitsis P; Ioannidou-Papagiannaki E; Kaidoglou A; Papakonstantinou C
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):593-7. PubMed ID: 17670726
[TBL] [Abstract][Full Text] [Related]
18. [Influence of chemotherapy on hematopoietic microenvironment and effect of autologous bone marrow stromal cell infusion on the recovery of hematopoiesis after chemotherapy].
Liu J; Ji S; Zhou L; Chen H
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):341-3. PubMed ID: 11877093
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mesenchymal cells derived from an chondrodysplasia punctuate patient and donors.
Shur I; Reish O; Ezra E; Benayahu D
J Cell Biochem; 2004 Sep; 93(1):112-9. PubMed ID: 15352168
[TBL] [Abstract][Full Text] [Related]
20. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.
Gan Y; Dai K; Zhang P; Tang T; Zhu Z; Lu J
Biomaterials; 2008 Oct; 29(29):3973-82. PubMed ID: 18639333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
